A5062015778- Hepatitis B Virus Studies
- Global Cancer Incidence and Screening
- Cervical Cancer and HPV Research
- Vaccine Coverage and Hesitancy
- Colorectal Cancer Screening and Detection
- Data-Driven Disease Surveillance
- Herpesvirus Infections and Treatments
MSD (Lithuania)
2024
MSD (Sweden)
2023
Background Varicella is usually a mild disease in children but may be life-threatening, especially adolescents and adults. Infection control measures implemented during the Coronavirus Disease 2019 (COVID-19) pandemic have suppressed varicella transmission, potentially creating an ‘immunity debt’, particularly countries without universal vaccination. Objectives To assess trends Google search engine queries for keywords as proxy infection rates to evaluate effect of vaccination on these...
Background The economic and mortality burden of cancer is high worldwide. In Europe, was responsible for 1.3 million deaths in 2020 incurred an estimated cost €50 billion from premature mortality. Human papillomavirus (HPV) hepatitis B virus (HBV) are among the leading causes infection-related cancers despite availability effective vaccines against these infections. This analysis productivity loss HBV- HPV-associated that could be preventable through vaccination across European regions.
Background A bivalent human papillomavirus vaccine (2vHPV) is currently used in the Netherlands; a nonavalent (9vHPV) also licensed.
Aim: The objective of this study was to estimate and compare the cost-effectiveness switching from a bivalent nonavalent human papillomavirus (HPV) vaccination program in Norway, incorporating all vaccine-preventable HPV-related diseases context latest cervical cancer screening program.Methods: A well-established dynamic transmission model natural history HPV infection disease adapted Norwegian population. We determined number cases subsequent deaths, economic burden under current standard...